Schalm Stefanie S, Tee Andrew R, Blenis John
Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
J Biol Chem. 2005 Mar 25;280(12):11101-6. doi: 10.1074/jbc.M413995200. Epub 2005 Jan 19.
The mammalian target of rapamycin, mTOR, is a Ser/Thr kinase that promotes cell growth and proliferation by activating ribosomal protein S6 kinase 1 (S6K1). We previously identified a conserved TOR signaling (TOS) motif in the N terminus of S6K1 that is required for its mTOR-dependent activation. Furthermore, our data suggested that the TOS motif suppresses an inhibitory function associated with the C terminus of S6K1. Here, we have characterized the mTOR-regulated inhibitory region within the C terminus. We have identified a conserved C-terminal "RSPRR" sequence that is responsible for an mTOR-dependent suppression of S6K1 activation. Deletion or mutations within this RSPRR motif partially rescue the kinase activity of the S6K1 TOS motif mutant (S6K1-F5A), and this rescued activity is rapamycin resistant. Furthermore, we have shown that the RSPRR motif significantly suppresses S6K1 phosphorylation at two phosphorylation sites (Thr-389 and Thr-229) that are crucial for S6K1 activation. Importantly, introducing both the Thr-389 phosphomimetic and RSPRR motif mutations into the catalytically inactive S6K1 mutant S6K1-F5A completely rescues its activity and renders it fully rapamycin resistant. These data show that the N-terminal TOS motif suppresses an inhibitory function mediated by the C-terminal RSPRR motif. We propose that the RSPRR motif interacts with a negative regulator of S6K1 that is normally suppressed by mTOR.
雷帕霉素的哺乳动物靶点mTOR是一种丝氨酸/苏氨酸激酶,通过激活核糖体蛋白S6激酶1(S6K1)促进细胞生长和增殖。我们之前在S6K1的N端鉴定出一个保守的TOR信号(TOS)基序,它是S6K1依赖mTOR激活所必需的。此外,我们的数据表明,TOS基序抑制了与S6K1 C端相关的抑制功能。在这里,我们对C端内mTOR调节的抑制区域进行了表征。我们鉴定出一个保守的C端“RSPRR”序列,它负责mTOR对S6K1激活的依赖性抑制。该RSPRR基序内的缺失或突变部分挽救了S6K1 TOS基序突变体(S6K1-F5A)的激酶活性,且这种挽救的活性对雷帕霉素具有抗性。此外,我们已经表明,RSPRR基序显著抑制S6K1在两个对S6K1激活至关重要的磷酸化位点(Thr-389和Thr-229)的磷酸化。重要的是,将Thr-389磷酸模拟物和RSPRR基序突变同时引入催化无活性的S6K1突变体S6K1-F5A中,完全挽救了其活性,并使其对雷帕霉素完全抗性。这些数据表明,N端TOS基序抑制了由C端RSPRR基序介导的抑制功能。我们提出,RSPRR基序与S6K1的一个负调节因子相互作用,该负调节因子通常被mTOR抑制。